Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasis-Reference-Cited by-同舟云学术

Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasis

Published:2017-02-25 Issue:19 Volume:8 Page:30621-30643
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Yang Yuan¹,Yang Howard H.²,Hu Ying²,Watson Peter H.³,Liu Huaitian²,Geiger Thomas R.¹,Anver Miriam R.⁴,Haines Diana C.⁴,Martin Philip⁴,Green Jeffrey E.¹,Lee Maxwell P.²,Hunter Kent W.¹,Wakefield Lalage M.¹

Affiliation:

1. Lab of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA

2. High Dimension Data Analysis Group, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA

3. British Columbia Cancer Agency, Vancouver Island Center, Victoria, British Columbia, Canada

4. Pathology Histotechnology Lab, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick MD, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progesterone receptor impairs immune respond and down-regulates sensitivity to anti-LAG3 in breast cancer;Translational Research;2024-09

2. Current Insights in Murine Models for Breast Cancer: Present, Past and Future;Current Pharmaceutical Design;2024-08

3. Erythropoietin induces tumour progression and CD39 expression on immune cells in a preclinical model of triple‐negative breast cancer;Immunology;2024-07-02

4. Syngeneic natural killer cell therapy activates dendritic and T cells in metastatic lungs and effectively treat low-burden metastases;2024-06-19

5. Syngeneic natural killer cell therapy activates dendritic and T cells in metastatic lungs and effectively treat low-burden metastases;2024-06-19